MMP-2 regulates rat ventral prostate development in vitro
β Scribed by Alexandre Bruni-Cardoso; Rafaela Rosa-Ribeiro; Vinicius D. B. Pascoal; Andre A. De Thomaz; Carlos L. Cesar; Hernandes F. Carvalho
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 929 KB
- Volume
- 239
- Category
- Article
- ISSN
- 1058-8388
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We have hypothesized that epithelial growth, branching, and canalization in the rodent ventral prostate (VP) would require matrix remodeling, and hence matrix metalloproteinase (MMP) activity. Therefore, the aim of this study was to evaluate the impact of blocking MMPβ2, using whole organ culture. siRNA was employed to inhibit MMPβ2 expression, and this was compared to GM6001's (a broadβspectrum MMP inhibitor) inhibition of general MMPs. These blocks impaired VP morphogenesis. MMPβ2 silencing reduced organ size, epithelial area, and the number of tips, as well as caused a dilation of the distal parts of the epithelium. Histology, 3βD reconstruction, biochemistry, and second harmonic generation (SHG) revealed that MMPβ2 silencing affected VP architecture by interfering in epithelial cell proliferation, lumen formation, and cellular organization of both epithelium and stroma, besides intense accumulation of collagen fibers. These data suggest that MMPβ2 plays important roles in prostate growth, being directly involved with epithelial morphogenesis. Developmental Dynamics 239:737β746, 2010. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
The rat prostate is composed of two anatomically well-defined regions designated as the ventral prostate (VP) and the dorsolateral prostate (DLP). W and DLP are known to exhibit marked cytological, biochemical, and functional differences including differential susceptibilities to carcinogens. While
BACKGROUND. Imbalance between cell proliferation and cell apoptosis has been considered a key factor in carcinogenesis. Prostatic intraepithelial neoplasia (PIN) is the most likely precancereous lesion and represents the major target for chemoprevention of prostate cancer. The proliferative and apop
BACKGROUND. Androgenic steroids regulate the development and size of the mammalian prostate gland. The mechanism(s) for this growth control might involve a direct effect on prostate cell proliferation and survival as well as more complex effects on the tissue environment supporting nourishment and o